Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
NCT04692441 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2024-05-24
Summary
High fat feeding (HFF) increases the risk of Alzheimer's disease (AD) but individuals who carry the AD risk gene E4 paradoxically improve after acute HFF. The investigators propose to further study this phenomenon with a clinical study to assess cerebral blood flow which can be measured by a technique called arterial spin labeling (ASL) on an MRI and is tightly related to brain metabolism.
Conditions
- Alzheimer Disease
- Dementia
Interventions
- DIETARY_SUPPLEMENT
-
Heavy Cream
100 ml of dairy cream with 40.4g of total fat, to ingest orally
Sponsors & Collaborators
-
National Institute on Aging (NIA)
collaborator NIH - lead OTHER
Principal Investigators
-
Angela J Hanson, MD · University of Washington
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Study to Understand Novel Biomarkers in Researching Dementia
NCT06547099 ·Status: RECRUITING
-
Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition
NCT00657813 ·Status: TERMINATED ·Phase: PHASE1
-
Multimodal Biomarkers for Diagnosis and Prognosis in VCI
NCT04604600 ·Status: UNKNOWN ·Phase: PHASE3
-
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
NCT05087888 ·Status: TERMINATED
-
A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)
NCT06682767 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease
NCT01325402 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD
NCT02225964 ·Status: COMPLETED
-
New Biomarker for Alzheimer's Disease Diagnostic
NCT01315639 ·Status: COMPLETED ·Phase: NA
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old
NCT02198586 ·Status: COMPLETED
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of [123I] AV83 and SPECT in Patients With Alzheimer Disease in Comparison to Healthy Controls
NCT00448799 ·Status: COMPLETED ·Phase: PHASE1
-
Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
NCT03588468 ·Status: COMPLETED ·Phase: NA
-
Development of an EEG Diagnostic for Alzheimer's Disease
NCT04954183 ·Status: COMPLETED
-
The Influence of Sequential Tau Protein and Amyloid Plaque Imaging Changes on Stroke Prognosis and Cognitive Outcome
NCT04572477 ·Status: UNKNOWN ·Phase: PHASE2
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
Arterial Spin Labeling (ASL) MRI for Cognitive Decline
NCT01727622 ·Status: COMPLETED
-
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
NCT00757939 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Biomarkers for Screening of Alzheimer's Disease
NCT06477484 ·Status: RECRUITING
-
New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study
NCT01773915 ·Status: UNKNOWN
-
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's Disease
NCT05582200 ·Status: RECRUITING
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants
NCT02685969 ·Status: RECRUITING
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1